Osaic Holdings
CADL icon

Osaic Holdings’s Candel Therapeutics CADL Stock Holding History

Osaic Holdings’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2K Sell
6,374
-105
-2% -$571 ﹤0.01% 5552
2025
Q4 		$36.6K Sell
6,479
-8,384
-56% -$45.1K ﹤0.01% 5457
2025
Q3 		$86K Buy
14,863
+2,988
+25% +$17.3K ﹤0.01% 4914
2025
Q2 		$60.1K Sell
11,875
-1,930
-14% -$9.93K ﹤0.01% 4915
2025
Q1 		$78K Buy
13,805
+10,778
+356% +$88.1K ﹤0.01% 4363
2024
Q4 		$26.3K Buy
+3,027
New +$17.9K ﹤0.01% 5154
2024
Q3 		– Sell
-25,800
Closed -$160K – 7414
2024
Q2 		$160K Buy
+25,800
New +$194K ﹤0.01% 3747

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings's CADL Position: Q1 2026 in Review

Osaic Holdings reduced its Candel Therapeutics (CADL) stake by 1.6% in Q1 2026, selling an estimated $571 and leaving 6,374 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5552.

Osaic Holdings first reported a position in CADL in Q2 2024 and has held it in 7 quarters since. The position peaked at $160K in Q2 2024. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Osaic Holdings held 6,374 shares of Candel Therapeutics worth $31.2K as of Q1 2026.
  • Osaic Holdings sold 105 Candel Therapeutics shares in Q1 2026, an estimated $571.
  • Candel Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5552 holding.
  • Osaic Holdings first reported a position in Candel Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Candel Therapeutics position peaked at $160K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.